Global Bio-pharma Market Research Report 2018

March 2018 | 116 pages | ID: G8D418F908EEN
QYResearch

Abstracts

In this report, the global Bio-pharma market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Bio-pharma in these regions, from 2013 to 2025 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Bio-pharma market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Pfizer
• F. Hoffmann-La Roche AG
• Johnson & Johnson Services
• Sanofi, Amgen
• AbbVie
• Merck & Co., Inc
• Biogen Idec
• Bayer AG
• Eli Lilly and Company
• Novartis AG GlaxoSmithKline Plc
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Abbott Laboratories

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Monoclonal Antibodies
• Recombinant Proteins
• Granulocyte-Colony Stimulating Factor (G-CSF)
• Interferons
• Recombinant Human Insulin
• Erythropoietin
• Vaccines
• Growth Hormones
• Purified Proteins
• Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Metabolic Disorders
• Oncology
• Neurological Disorders
• Cardiovascular Diseases
• Inflammatory and Infectious Diseases
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Bio-pharma Market Research Report 2018

1 BIO-PHARMA MARKET OVERVIEW

1.1 Product Overview and Scope of Bio-pharma
1.2 Bio-pharma Segment by Type (Product Category)
  1.2.1 Global Bio-pharma Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
  1.2.2 Global Bio-pharma Production Market Share by Type (Product Category) in 2017
  1.2.3 Monoclonal Antibodies
  1.2.4 Recombinant Proteins
  1.2.5 Granulocyte-Colony Stimulating Factor (G-CSF)
  1.2.6 Interferons
  1.2.7 Recombinant Human Insulin
  1.2.8 Erythropoietin
  1.2.9 Vaccines
  1.2.10 Growth Hormones
  1.2.11 Purified Proteins
  1.2.12 Others
1.3 Global Bio-pharma Segment by Application
  1.3.1 Bio-pharma Consumption (Sales) Comparison by Application (2013-2025)
  1.3.2 Metabolic Disorders
  1.3.3 Oncology
  1.3.4 Neurological Disorders
  1.3.5 Cardiovascular Diseases
  1.3.6 Inflammatory and Infectious Diseases
  1.3.7 Others
1.4 Global Bio-pharma Market by Region (2013-2025)
  1.4.1 Global Bio-pharma Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
  1.4.2 North America Status and Prospect (2013-2025)
  1.4.3 Europe Status and Prospect (2013-2025)
  1.4.4 China Status and Prospect (2013-2025)
  1.4.5 Japan Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Status and Prospect (2013-2025)
  1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Bio-pharma (2013-2025)
  1.5.1 Global Bio-pharma Revenue Status and Outlook (2013-2025)
  1.5.2 Global Bio-pharma Capacity, Production Status and Outlook (2013-2025)

2 GLOBAL BIO-PHARMA MARKET COMPETITION BY MANUFACTURERS

2.1 Global Bio-pharma Capacity, Production and Share by Manufacturers (2013-2018)
  2.1.1 Global Bio-pharma Capacity and Share by Manufacturers (2013-2018)
  2.1.2 Global Bio-pharma Production and Share by Manufacturers (2013-2018)
2.2 Global Bio-pharma Revenue and Share by Manufacturers (2013-2018)
2.3 Global Bio-pharma Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Bio-pharma Manufacturing Base Distribution, Sales Area and Product Type
2.5 Bio-pharma Market Competitive Situation and Trends
  2.5.1 Bio-pharma Market Concentration Rate
  2.5.2 Bio-pharma Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL BIO-PHARMA CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2013-2018)

3.1 Global Bio-pharma Capacity and Market Share by Region (2013-2018)
3.2 Global Bio-pharma Production and Market Share by Region (2013-2018)
3.3 Global Bio-pharma Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 GLOBAL BIO-PHARMA SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2013-2018)

4.1 Global Bio-pharma Consumption by Region (2013-2018)
4.2 North America Bio-pharma Production, Consumption, Export, Import (2013-2018)
4.3 Europe Bio-pharma Production, Consumption, Export, Import (2013-2018)
4.4 China Bio-pharma Production, Consumption, Export, Import (2013-2018)
4.5 Japan Bio-pharma Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Bio-pharma Production, Consumption, Export, Import (2013-2018)
4.7 India Bio-pharma Production, Consumption, Export, Import (2013-2018)

5 GLOBAL BIO-PHARMA PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Bio-pharma Production and Market Share by Type (2013-2018)
5.2 Global Bio-pharma Revenue and Market Share by Type (2013-2018)
5.3 Global Bio-pharma Price by Type (2013-2018)
5.4 Global Bio-pharma Production Growth by Type (2013-2018)

6 GLOBAL BIO-PHARMA MARKET ANALYSIS BY APPLICATION

6.1 Global Bio-pharma Consumption and Market Share by Application (2013-2018)
6.2 Global Bio-pharma Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL BIO-PHARMA MANUFACTURERS PROFILES/ANALYSIS

7.1 Pfizer
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Bio-pharma Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Pfizer Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.1.4 Main Business/Business Overview
7.2 F. Hoffmann-La Roche AG
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Bio-pharma Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 F. Hoffmann-La Roche AG Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.2.4 Main Business/Business Overview
7.3 Johnson & Johnson Services
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Bio-pharma Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Johnson & Johnson Services Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.3.4 Main Business/Business Overview
7.4 Sanofi, Amgen
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Bio-pharma Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Sanofi, Amgen Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.4.4 Main Business/Business Overview
7.5 AbbVie
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Bio-pharma Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 AbbVie Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.5.4 Main Business/Business Overview
7.6 Merck & Co., Inc
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Bio-pharma Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Merck & Co., Inc Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Biogen Idec
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Bio-pharma Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Biogen Idec Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Bayer AG
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Bio-pharma Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Bayer AG Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.8.4 Main Business/Business Overview
7.9 Eli Lilly and Company
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Bio-pharma Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Eli Lilly and Company Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.9.4 Main Business/Business Overview
7.10 Novartis AG GlaxoSmithKline Plc
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Bio-pharma Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.10.4 Main Business/Business Overview
7.11 Bristol-Myers Squibb Company
7.12 AstraZeneca PLC
7.13 Abbott Laboratories

8 BIO-PHARMA MANUFACTURING COST ANALYSIS

8.1 Bio-pharma Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Bio-pharma

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Bio-pharma Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Bio-pharma Major Manufacturers in 2017
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL BIO-PHARMA MARKET FORECAST (2018-2025)

12.1 Global Bio-pharma Capacity, Production, Revenue Forecast (2018-2025)
  12.1.1 Global Bio-pharma Capacity, Production and Growth Rate Forecast (2018-2025)
  12.1.2 Global Bio-pharma Revenue and Growth Rate Forecast (2018-2025)
  12.1.3 Global Bio-pharma Price and Trend Forecast (2018-2025)
12.2 Global Bio-pharma Production, Consumption, Import and Export Forecast by Region (2018-2025)
  12.2.1 North America Bio-pharma Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.2 Europe Bio-pharma Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.3 China Bio-pharma Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.4 Japan Bio-pharma Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.5 Southeast Asia Bio-pharma Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.6 India Bio-pharma Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Bio-pharma Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Bio-pharma Consumption Forecast by Application (2018-2025)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Bio-pharma
Figure Global Bio-pharma Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Bio-pharma Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Monoclonal Antibodies
Table Major Manufacturers of Monoclonal Antibodies
Figure Product Picture of Recombinant Proteins
Table Major Manufacturers of Recombinant Proteins
Figure Product Picture of Granulocyte-Colony Stimulating Factor (G-CSF)
Table Major Manufacturers of Granulocyte-Colony Stimulating Factor (G-CSF)
Figure Product Picture of Interferons
Table Major Manufacturers of Interferons
Figure Product Picture of Recombinant Human Insulin
Table Major Manufacturers of Recombinant Human Insulin
Figure Product Picture of Erythropoietin
Table Major Manufacturers of Erythropoietin
Figure Product Picture of Vaccines
Table Major Manufacturers of Vaccines
Figure Product Picture of Growth Hormones
Table Major Manufacturers of Growth Hormones
Figure Product Picture of Purified Proteins
Table Major Manufacturers of Purified Proteins
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Bio-pharma Consumption (K Pcs) by Applications (2013-2025)
Figure Global Bio-pharma Consumption Market Share by Applications in 2017
Figure Metabolic Disorders Examples
Table Key Downstream Customer in Metabolic Disorders
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Neurological Disorders Examples
Table Key Downstream Customer in Neurological Disorders
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Inflammatory and Infectious Diseases Examples
Table Key Downstream Customer in Inflammatory and Infectious Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Bio-pharma Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2013-2025)
Figure North America Bio-pharma Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Bio-pharma Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Bio-pharma Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Bio-pharma Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Bio-pharma Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Bio-pharma Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Bio-pharma Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Bio-pharma Capacity, Production (K Pcs) Status and Outlook (2013-2025)
Figure Global Bio-pharma Major Players Product Capacity (K Pcs) (2013-2018)
Table Global Bio-pharma Capacity (K Pcs) of Key Manufacturers (2013-2018)
Table Global Bio-pharma Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Bio-pharma Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Bio-pharma Capacity (K Pcs) of Key Manufacturers in 2018
Figure Global Bio-pharma Major Players Product Production (K Pcs) (2013-2018)
Table Global Bio-pharma Production (K Pcs) of Key Manufacturers (2013-2018)
Table Global Bio-pharma Production Share by Manufacturers (2013-2018)
Figure 2017 Bio-pharma Production Share by Manufacturers
Figure 2017 Bio-pharma Production Share by Manufacturers
Figure Global Bio-pharma Major Players Product Revenue (Million USD) (2013-2018)
Table Global Bio-pharma Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Bio-pharma Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Bio-pharma Revenue Share by Manufacturers
Table 2018 Global Bio-pharma Revenue Share by Manufacturers
Table Global Market Bio-pharma Average Price (USD/Pcs) of Key Manufacturers (2013-2018)
Figure Global Market Bio-pharma Average Price (USD/Pcs) of Key Manufacturers in 2017
Table Manufacturers Bio-pharma Manufacturing Base Distribution and Sales Area
Table Manufacturers Bio-pharma Product Category
Figure Bio-pharma Market Share of Top 3 Manufacturers
Figure Bio-pharma Market Share of Top 5 Manufacturers
Table Global Bio-pharma Capacity (K Pcs) by Region (2013-2018)
Figure Global Bio-pharma Capacity Market Share by Region (2013-2018)
Figure Global Bio-pharma Capacity Market Share by Region (2013-2018)
Figure 2017 Global Bio-pharma Capacity Market Share by Region
Table Global Bio-pharma Production by Region (2013-2018)
Figure Global Bio-pharma Production (K Pcs) by Region (2013-2018)
Figure Global Bio-pharma Production Market Share by Region (2013-2018)
Figure 2017 Global Bio-pharma Production Market Share by Region
Table Global Bio-pharma Revenue (Million USD) by Region (2013-2018)
Table Global Bio-pharma Revenue Market Share by Region (2013-2018)
Figure Global Bio-pharma Revenue Market Share by Region (2013-2018)
Table 2017 Global Bio-pharma Revenue Market Share by Region
Figure Global Bio-pharma Capacity, Production (K Pcs) and Growth Rate (2013-2018)
Table Global Bio-pharma Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table North America Bio-pharma Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Europe Bio-pharma Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table China Bio-pharma Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Japan Bio-pharma Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Southeast Asia Bio-pharma Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table India Bio-pharma Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Global Bio-pharma Consumption (K Pcs) Market by Region (2013-2018)
Table Global Bio-pharma Consumption Market Share by Region (2013-2018)
Figure Global Bio-pharma Consumption Market Share by Region (2013-2018)
Figure 2017 Global Bio-pharma Consumption (K Pcs) Market Share by Region
Table North America Bio-pharma Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Europe Bio-pharma Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table China Bio-pharma Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Japan Bio-pharma Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Southeast Asia Bio-pharma Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table India Bio-pharma Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Global Bio-pharma Production (K Pcs) by Type (2013-2018)
Table Global Bio-pharma Production Share by Type (2013-2018)
Figure Production Market Share of Bio-pharma by Type (2013-2018)
Figure 2017 Production Market Share of Bio-pharma by Type
Table Global Bio-pharma Revenue (Million USD) by Type (2013-2018)
Table Global Bio-pharma Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Bio-pharma by Type (2013-2018)
Figure 2017 Revenue Market Share of Bio-pharma by Type
Table Global Bio-pharma Price (USD/Pcs) by Type (2013-2018)
Figure Global Bio-pharma Production Growth by Type (2013-2018)
Table Global Bio-pharma Consumption (K Pcs) by Application (2013-2018)
Table Global Bio-pharma Consumption Market Share by Application (2013-2018)
Figure Global Bio-pharma Consumption Market Share by Applications (2013-2018)
Figure Global Bio-pharma Consumption Market Share by Application in 2017
Table Global Bio-pharma Consumption Growth Rate by Application (2013-2018)
Figure Global Bio-pharma Consumption Growth Rate by Application (2013-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Bio-pharma Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pfizer Bio-pharma Production Growth Rate (2013-2018)
Figure Pfizer Bio-pharma Production Market Share (2013-2018)
Figure Pfizer Bio-pharma Revenue Market Share (2013-2018)
Table F. Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche AG Bio-pharma Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche AG Bio-pharma Production Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche AG Bio-pharma Production Market Share (2013-2018)
Figure F. Hoffmann-La Roche AG Bio-pharma Revenue Market Share (2013-2018)
Table Johnson & Johnson Services Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Services Bio-pharma Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Johnson & Johnson Services Bio-pharma Production Growth Rate (2013-2018)
Figure Johnson & Johnson Services Bio-pharma Production Market Share (2013-2018)
Figure Johnson & Johnson Services Bio-pharma Revenue Market Share (2013-2018)
Table Sanofi, Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi, Amgen Bio-pharma Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sanofi, Amgen Bio-pharma Production Growth Rate (2013-2018)
Figure Sanofi, Amgen Bio-pharma Production Market Share (2013-2018)
Figure Sanofi, Amgen Bio-pharma Revenue Market Share (2013-2018)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Bio-pharma Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AbbVie Bio-pharma Production Growth Rate (2013-2018)
Figure AbbVie Bio-pharma Production Market Share (2013-2018)
Figure AbbVie Bio-pharma Revenue Market Share (2013-2018)
Table Merck & Co., Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co., Inc Bio-pharma Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck & Co., Inc Bio-pharma Production Growth Rate (2013-2018)
Figure Merck & Co., Inc Bio-pharma Production Market Share (2013-2018)
Figure Merck & Co., Inc Bio-pharma Revenue Market Share (2013-2018)
Table Biogen Idec Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Idec Bio-pharma Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Biogen Idec Bio-pharma Production Growth Rate (2013-2018)
Figure Biogen Idec Bio-pharma Production Market Share (2013-2018)
Figure Biogen Idec Bio-pharma Revenue Market Share (2013-2018)
Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer AG Bio-pharma Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bayer AG Bio-pharma Production Growth Rate (2013-2018)
Figure Bayer AG Bio-pharma Production Market Share (2013-2018)
Figure Bayer AG Bio-pharma Revenue Market Share (2013-2018)
Table Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly and Company Bio-pharma Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Bio-pharma Production Growth Rate (2013-2018)
Figure Eli Lilly and Company Bio-pharma Production Market Share (2013-2018)
Figure Eli Lilly and Company Bio-pharma Revenue Market Share (2013-2018)
Table Novartis AG GlaxoSmithKline Plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Production Growth Rate (2013-2018)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Production Market Share (2013-2018)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bio-pharma
Figure Manufacturing Process Analysis of Bio-pharma
Figure Bio-pharma Industrial Chain Analysis
Table Raw Materials Sources of Bio-pharma Major Manufacturers in 2017
Table Major Buyers of Bio-pharma
Table Distributors/Traders List
Figure Global Bio-pharma Capacity, Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Bio-pharma Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Bio-pharma Price (Million USD) and Trend Forecast (2018-2025)
Table Global Bio-pharma Production (K Pcs) Forecast by Region (2018-2025)
Figure Global Bio-pharma Production Market Share Forecast by Region (2018-2025)
Table Global Bio-pharma Consumption (K Pcs) Forecast by Region (2018-2025)
Figure Global Bio-pharma Consumption Market Share Forecast by Region (2018-2025)
Figure North America Bio-pharma Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure North America Bio-pharma Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Bio-pharma Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Europe Bio-pharma Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Bio-pharma Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Bio-pharma Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure China Bio-pharma Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Bio-pharma Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Bio-pharma Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Japan Bio-pharma Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Bio-pharma Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Bio-pharma Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Southeast Asia Bio-pharma Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Bio-pharma Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Bio-pharma Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure India Bio-pharma Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Bio-pharma Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Bio-pharma Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Table Global Bio-pharma Production (K Pcs) Forecast by Type (2018-2025)
Figure Global Bio-pharma Production (K Pcs) Forecast by Type (2018-2025)
Table Global Bio-pharma Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Bio-pharma Revenue Market Share Forecast by Type (2018-2025)
Table Global Bio-pharma Price Forecast by Type (2018-2025)
Table Global Bio-pharma Consumption (K Pcs) Forecast by Application (2018-2025)
Figure Global Bio-pharma Consumption (K Pcs) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source